Company to shift exploration to promising East Zone in 2022.
WINDSOR, NS , Dec. 22, 2021 /CNW/ - MLK Gold Ltd. (CSE: MLK) ("MLK" or the "Company"), a growth-oriented gold exploration company headquartered in Windsor, Nova Scotia , is pleased to announce assay results from its 2021 fall exploration program at its 100 percent owned Golden Eye Property at Little River in southern Newfoundland and the Manuels low sulphidation epithermal gold occurrence on the Avalon Peninsula.
MLK President & CEO, Paul Smith , stated: "The results of the 2021 exploration program continue to warrant further exploration as a thick glacial drift is present in both areas and historical exploration has been minimal, especially at the Manuels property. This provides a significant opportunity to further increase MLK's mineralized envelope, which remains a prime objective of our exploration program. We look forward to initiating our Q1/2022 to Q4/2022 agenda which will include a 1,000-metre drilling plan, evaluation of alteration and geological surveys, and establish better controls on structure setting towards the end of 2022."
The Company is reporting assay results from a total of 90 rock samples of quartz vein material (both bedrock and glacially derived) consisting of several different morphological vein types.
The highest assay was 8.95 g/t Au with all other assays considered insignificant.
Samples were collected from the West Zone covering a strike length of approximately 3.1 kilometers.
Associated mineralogy of the samples included, arsenopyrite, pyrite, chalcopyrite, bornite, chlorite, plagioclase, and muscovite/sericite in addition to quartz.
Historical grab sample assay results on the property have returned values up to 18.9 g/t Au while diamond drill core assayed up to 2.95 g/t Au over 0.7 metres (DDH: LR-10-02) at the West Zone.
Map can be found HERE.
The West Zone consists of a series of large, north-south trending, en echelon tension gashes filled with quartz and represent one major veining event with two younger vein emplacement events. Individual veins are up to two-plus metres thick and display multiple injection of silica-rich fluids. The en echelon arrays are up to 20 metres wide with a strike length up to 75 metres. These arrays are spaced at both regular and semi-predictable intervals (200-300 metres) and form a hanging wall sequence to the mineralization in the East Zone.
The Company is encouraged by mineralization occurring along a strike of the Canstar Resources Golden Baie Project where grab samples assayed up to 4,485 g/t Au. This has resulted in the East Zone being a strong focus of the Company's 2022 exploration at the Golden Eye property.
The Company carried out soil sampling and a six-hole diamond drilling program on its 100 percent owned low sulphidation, epithermal Manuels gold property near the Town of Conception Bay South on the Avalon Peninsula of Newfoundland .
Soil sampling on the property returned silver values up to 12.2 g/t Ag over a significant area, but gold values did not correspond with anomalous silver. The soil sample grid will be expanded in 2022 and further evaluate the anomalous silver geochemistry discovered on the property.
The drill program was focused on depth continuity of two low-grade (~0.5 g/t Au) gold occurrences hosted in deep red coloured silicified rhyolite. At the Boxcar breccia occurrence, assay results from drill core returned up to 0.21 g/t Au with the width of the mineralized zone increased from approximately one metre to more than 11 metres.
Drilling efforts to intersect deeper mineralization under both the Boxcar and the Farmers Field occurrence resulted in drilling difficulties from block-faulting and both areas were abandoned following a total of 594 metres being drilled.
With a drilling exploration plan initiated for 2022, the Company also engaged Ottawa -based heavy mineral geochemistry and exploration firm, Overburden Drilling Management Ltd. (ODM), to undertake glacial till sampling programs on selected portions of the Company's Caledonia Brook property. With MLK's earlier collection of 23 samples along the northwestern portion of the property, ODM has now collected an additional 111 samples, each weighing approximately 11 kilograms. Results are expected to be reported on all 134 samples in late January once mineral separation and identification has been completed by ODM.
Executive Chairman & Director, Bill Fleming , says the Company's plan to increase exploration efforts and improve target delineation as part of an aggressive 2022 agenda.
"We expect to demonstrate the strength of our operations and proven operating model as we enter a period of significant investment in our exploration plan. In 2022, our focus will be on delivering long-term value to all of our stakeholders and staff through our ongoing commitment to sustainable, inclusive, and responsible mining."
Qualified Persons and 43-101 Disclosure
Paul Smith , P. Geo., President & CEO for the Company, is the designated Qualified Person for this news release within the meaning of National Instrument 43-101 ("NI 43-101") and has reviewed and verified that the technical information contained herein is accurate and approves of the written disclosure of same.
Founded in 2018, MLK Gold Ltd. is quickly emerging as one of Atlantic Canada's premiere resource exploration companies offering exposure to gold and the strategic metal representing a unique mix of discovery and resource development potential. Invested in a portfolio of gold projects in mining and mineral-rich Newfoundland , MLK's plan is to capitalize on the province's ranking as one of the world's top 10 mining jurisdictions and expand into a long-life, financially sound gold-mining company.
Additional information about the Company and its activities may be found on the Company's website at www.mlkgold.com and under the Company's profile at www.sedar.com.
To view the Company's recent promotional video, please click HERE.
This news release contains certain forward-looking statements. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. The Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2021/22/c6778.html
Every investor in NIO Inc. ( NYSE:NIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...
As we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Below are four stocks that I believe are likely to find their way into my portfolio in 2022. A year ago, I was completely against electric vehicle (EV) manufacturer Nio (NYSE: NIO).
Since the Great Recession officially ended in 2009, growth stocks have been the driving force on Wall Street. Low lending rates, massive government spending, and the Federal Reserve providing an abundant pool of cheap capital have incentivized businesses to hire, innovate, and acquire other companies. The chickens are now coming home to roost in terms of runaway inflation, and though the Fed has indicated rate hikes are coming to combat high prices, effects won't be felt right away.
It's been a dreadful year for Citigroup (NYSE: C) in terms of stock price performance, with shares of the megabank down about 1% this year. The KBW Nasdaq Bank Index, which tracks large bank stocks, is up nearly 35% this year, showing just how much Citigroup has lagged the broader sector. Trading at beaten-down levels, can Citigroup turn it around in 2022?
ClearBridge Investments, an investment management firm, published its “Small Cap Value Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge Small Cap Value Strategy outperformed the Russell 2000 Value Index, the Strategy’s benchmark, during the third quarter of 2021. You can take a look at the fund’s […]
The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.
Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.
Web 3.0 is widely considered to be the next frontier of internet technology, making the metaverse a golden macrotrend for retail investors. The metaverse refers to an easily scalable real-time virtual reality or mixed reality world, comprising several interoperable, immersive, and interactive 3D environments. The metaverse is also expected to maintain all relevant information about payments, identity, and history across user sessions.
This mix of industrial and renewable energy companies could be a great way to generate passive income next year.
Sorrento Therapeutics Inc. said Monday that "initial" laboratory testing of its Covistix COVID-19 virus rapid antigen detection test "significantly outperforms" in the detection of the omicron variant. The stock slipped 1.1% in morning trading. The company said Covistix, which is currently approved in Mexico and Brazil and is CE marked in Europe, was able to detect the omicron N protein "at a significantly lower level" than other commercially available tests in a laboratory setting, and in an in
These last few weeks of 2021 have seen increased market volatility. Along with Omicron fears, the market fluctuations have come just as Wall Street is digesting the fact of a new Fed policy in the New Year, including the tightening up of monetary policy and at least one, probably more, interest rate hikes. The Fed’s easy money has been supportive for the better part of the past decade or more, and investors are rightly wondering how the market will adapt. Looking ahead, Wedbush’s Daniel Ives is
Genetic testing company Invitae (NYSE: NVTA) has seen its shares tumble from their highs despite aggressively ramping up its test volumes this year. Investors could buy the dip on Invitae, but they shouldn't ignore a major hang-up on its business model. Invitae generates revenue by administering genetic tests while steadily also building a genome information database over time.
Investors in Nio (NYSE: NIO) have been on a roller-coaster ride in 2021, but most of that ride has been downhill. As of the close of trading on Friday, shares of the Chinese electric vehicle (EV) company were down by around 54% from its highest-ever trading price of $66.99 in early January and off by more than 37% year to date. Among other issues, investors are concerned about the rapidly spreading omicron COVID-19 variant and its possible impact on the global economy, ongoing semiconductor chip shortages, increasing U.S. regulatory scrutiny on foreign companies, and fears that a debt default by massive Chinese property developer Evergrande Group might set off a financial crisis in Nio's home market.
Billionaire investor Warren Buffett prioritizes not losing money. Two meme stocks that are probable money-losers next year are Ocugen (NASDAQ: OCGN) and Rivian (NASDAQ: RIVN). Through the first nine months of 2021, healthcare company Ocugen didn't generate any revenue.
If you have $100 at the ready not needed for bills or emergencies and a brokerage that allows fractional share purchases, you have enough to buy into the following pair of no-brainer stocks right now. Palantir Technologies (NYSE: PLTR) is the Liam Neeson of data analytics stocks: It has a very particular set of skills that were acquired over a very long career. The U.S. military is also a prime customer, using Palantir's technology to coordinate millions of troops around the world.
Stocks rose ahead of the traditional Santa Claus rally. Tesla is still rising. AMD leads stocks flashing buy signals.
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
China's BYD will look to top the 100,000 vehicles mark, after setting a sixth monthly EV sales record. Nio stock rose.
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
There's no denying that 2021 has been a rough year for many biotech stocks. The shares of quite a few big and small biotech companies alike are set to finish the year in negative territory. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novartis (NYSE: NVS), and Vertex Pharmaceuticals (NASDAQ: VRTX).